Fund shareholders of MATINAS BIOPHARMA HOLDINGS INC
ISIN US5768103039 · United States · LEI 549300TGHXVKQ7EJRO41
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 67.8K $
- Share of capital
- 0.6 % of 14.7M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 40,110 | 24.5K $ | 0.27 % | as of Jun 30, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 39,583 | 32.1K $ | 0.00 % | 0.27 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,652 | 6.2K $ | 0.05 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 6,123 | 5K $ | 0.04 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 93,468 | +10.9 % |
| 2026Q2 | 4 | 0 | 84,268 | 0.0 % |
| 2026Q1 | 4 | 0 | 84,268 | -0.4 % |
| 2025Q4 | 4 | 0 | 84,564 | -17.9 % |
| 2025Q3 | 4 | 0 | 103,049 | +3.6 % |
| 2025Q2 | 4 | -1 | 99,479 | -40.5 % |
| 2025Q1 | 5 | 0 | 167,265 | -9.6 % |
| 2024Q4 | 5 | 185,070 |
Institutional managers
25 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 65,170 | 32.6K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 51,698 | 25.8K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 49,650 | 24.8K $ | as of Mar 31, 2026 |
| Holos Integrated Wealth LLC | 32,480 | 16.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 28,570 | 14.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 20,706 | 10.4K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 15,322 | 7.7K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,328 | 7.2K $ | as of Mar 31, 2026 |
| Sargent Investment Group, LLC | 12,720 | 6.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,853 | 1.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 344 | 172 $ | as of Mar 31, 2026 |
| Costello Asset Management, INC | 200 | 100 $ | as of Mar 31, 2026 |
| UBS Group AG | 184 | 92 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 102 | 51 $ | as of Mar 31, 2026 |
| Steward Partners Investment Advisory, LLC | 61 | 31 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 60 | 34 $ | as of Mar 31, 2026 |
| EverSource Wealth Advisors, LLC | 60 | 30 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 50 | 25 $ | as of Mar 31, 2026 |
| VISION FINANCIAL MARKETS LLC | 40 | 20 $ | as of Mar 31, 2026 |
| ROTHSCHILD INVESTMENT LLC | 14 | 7 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 11 | 6 $ | as of Mar 31, 2026 |
| FMR LLC | 7 | 4 $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 5 | 3 $ | as of Mar 31, 2026 |
| MAI Capital Management | 2 | 1 $ | as of Mar 31, 2026 |
| Bogart Wealth, LLC | 2 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of MATINAS BIOPHARMA HOLDINGS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sanitam Partners LLC and 1 other | 9.99 % | 2,972,524 | as of Jun 10, 2026 · SCHEDULE 13D |
| Hezbay Holdings LLC | 9.54 % | 1,306,488 | as of Jul 13, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of MATINAS BIOPHARMA HOLDINGS INC". https://titelia.com/en/stocks/matinas-biopharma-holdings-inc-US5768103039